The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 03, 2024
Filed:
Dec. 20, 2019
Applicant:
Gambro Lundia Ab, Lund, SE;
Inventor:
Stephen F. Marino, Berlin, DE;
Assignee:
GAMBRO LUNDIA AB, Lund, SE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61M 1/34 (2006.01); A61K 38/00 (2006.01); A61K 38/48 (2006.01); A61K 39/385 (2006.01); A61K 47/50 (2017.01); A61K 47/68 (2017.01); A61K 47/69 (2017.01);
U.S. Cl.
CPC ...
A61M 1/3486 (2014.02); A61K 38/00 (2013.01); A61K 38/482 (2013.01); A61K 39/385 (2013.01); A61K 47/50 (2017.08); A61K 47/6849 (2017.08); A61K 47/6957 (2017.08); A61M 2202/0445 (2013.01); C07K 2317/92 (2013.01);
Abstract
The invention relates to a blood treatment device configured to remove anti-neutrophil cytoplasmic antibodies (ANCAs) from the blood or blood plasma of a person in need thereof in an extracorporeal blood circuit, wherein the device comprises a matrix, and wherein said matrix comprises a monomeric form of proteinase 3 (PR3). The invention further relates to an extra-corporeal blood circuit comprising a blood treatment device of the invention and to the blood treatment device for use as a medicament or to methods of treating a medical condition associated with ANCA.